Welcome to our dedicated page for Stryker Corporation news (Ticker: $SYK), a resource for investors and traders seeking the latest updates and insights on Stryker Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Stryker Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Stryker Corporation's position in the market.
Rhea-AI Summary
Stryker (SYK) launches Prophecy Footprint, expanding the Prophecy Surgical Planning system to offer comprehensive surgical planning across the entire foot. The system will be demonstrated at the American College of Foot and Ankle Surgeons Annual Meeting. Also, the company celebrates the tenth anniversary of the Infinity Total Ankle System, with a 98.8% survivorship at the two-year mark.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
-
Rhea-AI Summary
Stryker (NYSE:SYK) reported strong financial results for the fourth quarter and full year of 2023, with net sales increasing 11.8% to $5.8 billion in the quarter and 11.1% to $20.5 billion for the full year. Adjusted EPS increased 15.3% to $3.46 in the quarter and 13.5% to $10.60 for the full year. The company expects 2024 organic net sales growth to be in the range of 7.5% to 9.0% and adjusted net earnings per diluted share to be in the range of $11.70 to $12.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
-
Rhea-AI Summary
Stryker's Gamma4 Hip Fracture Nailing System has been used in over 19,000 cases since its launch in August 2022, across more than 850 facilities. The system has expanded with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. It is indicated for the treatment of stable and unstable fractures, as well as for bone stabilization and correction of deformities in various regions of the femur. The press release emphasizes Stryker's commitment to providing innovative orthopaedic solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
Rhea-AI Summary
Stryker (SYK) announces successful completion of the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance, a new tool for surgeons to execute pre-operative plans with 3D imaging and operate with more precision and consistency.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
-
Rhea-AI Summary
Stryker (SYK) achieved a historic milestone by surpassing $20 billion in annual sales for the first time in December 2023. Kevin Lobo, Chair and CEO, expressed excitement over this achievement, highlighting the positive impact on customers and patients. Stryker will provide further details on its 2023 financial performance during the Q4 and Full Year Earnings Call on January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.57%
Tags
-
Rhea-AI Summary
Stryker (NYSE:SYK) will report financial results for Q4 and full year 2023 on January 30, 2024. The press release will include summary financial information, and a webcast will be hosted to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
News
Rhea-AI Summary
Stryker (SYK) has executed a binding offer to acquire SERF SAS, a France-based joint replacement company known for its innovations in hip implants. The acquisition is expected to complement Stryker's global joint replacement portfolio and expand its presence in France and across Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
-
Rhea-AI Summary
Stryker (NYSE:SYK) plans to nominate Rachel Ruggeri for its Board of Directors at the 2024 Annual Meeting of Shareholders. With over 25 years of global finance leadership experience, Rachel currently serves as the executive vice president and chief financial officer at Starbucks. She is responsible for the global finance function, including developing and executing financial strategies. Rachel has held various finance leadership positions within Starbucks and has a BA from the University of Puget Sound and an MBA from Washington State University.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
-
Rhea-AI Summary
Stryker (NYSE:SYK) announced that Dr. Srikant Datar will not stand for re-election at Stryker's 2024 Annual Meeting of Shareholders. Dr. Datar is the Dean of the Harvard Business School and George F. Baker Professor of Business Administration. He has a strong academic and business background, and his contributions have helped Stryker accelerate global growth through focus on organic and M&A innovation. Stryker is a leading medical technology company offering innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine, impacting over 130 million patients annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
Rhea-AI Summary
Stryker (NYSE:SYK) has announced a 6.7% increase in its quarterly dividend to $0.80 per share, payable on January 31, 2024, to shareholders of record as of December 29, 2023. Kevin Lobo, Chair and CEO, stated that this increase aligns with the company's capital allocation strategy, reflecting strong growth and solid financial performance. Stryker is a leading medical technology company offering innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine, impacting over 130 million patients annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
Stryker Corporation
NYSE:SYK
SYK Rankings
SYK Stock Data
124.43B
340.60M
5.39%
78.85%
1.12%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
KALAMAZOO
About SYK
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.